Marché de la technologie des enzymes médicales – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00020828
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 231
Buy Now

La technologie des enzymes médicales devrait atteindre 6 700,00 millions de dollars US d'ici 2028 contre 4 012,57 millions de dollars US en 2020 ; on estime qu'il croîtra à un TCAC de 6,7 % de 2021 à 2028.



Le marché de la technologie des enzymes médicales a été analysé sur la base du type d'enzyme, de l'application et de la région. Le marché basé sur la région est segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique, et en Amérique du Sud et centrale. Le rapport met l'accent sur des paramètres tels que les tendances du marché, les avancées technologiques, la dynamique du marché et l'analyse du paysage concurrentiel de l'entreprise leader pour offrir des informations et une analyse approfondie du marché de la technologie des enzymes médicales. Il comprend également l'analyse de la pandémie de COVID-19 sur le marché dans toutes les régions clés.



Régions lucratives pour le marché de la technologie des enzymes médicales



Aperçu du marché



Les progrès de l'ingénierie enzymatique vont devenir une tendance clé dans le domaine des enzymes médicales Marché de la technologie



L'ingénierie enzymatique joue un rôle fondamental dans le développement de biocatalyseurs efficaces pour la biotechnologie, les sciences de la vie et la biomédecine. L'ingénierie enzymatique est le processus d'adaptation de nouveaux biocatalyseurs aux propriétés améliorées en modifiant leurs séquences d'acides aminés. Malgré l'immensité des modifications possibles, cette procédure a déjà donné des résultats remarquables sous la forme de conceptions uniques et d'optimisation d'enzymes pour la biosynthèse chimique et pharmaceutique, la médecine régénérative, la production alimentaire, la biodégradation des déchets et la biodétection.



À part à partir des approches classiques de conception rationnelle et d'évolution dirigée, les méthodes d'apprentissage automatique (ML) sont de plus en plus appliquées pour trouver des modèles dans les données qui aident à prédire les structures des protéines ; améliorer la stabilité, la solubilité et la fonction des enzymes ; prédire la spécificité du substrat ; et guider la conception rationnelle des protéines. L'apprentissage automatique est une troisième approche de la conception de nouveaux biocatalyseurs, qui attire l'attention depuis quelques décennies. Contrairement aux méthodes de conception rationnelles basées sur un modèle, cette stratégie est basée sur les données car elle identifie des modèles dans les données existantes pour prédire les propriétés d'une entrée inconnue mais similaire. En janvier 2020, Curative Enzymes, un fournisseur de produits et de services, a lancé le service d'ingénierie et de modification d'enzymes pour aider les principaux clients.



Avec l'émergence de nouvelles techniques et méthodes pour reconstruire et concevoir des enzymes, travaillant dans l'ingénierie des protéines est devenu plus pratique, mettant en lumière de nouveaux biocatalyseurs et molécules semi-synthétiques ou synthétiques pour des applications industrielles. Ainsi, les progrès de l'ingénierie enzymatique sont susceptibles d'être une tendance prédominante sur le marché au cours de la période de prévision.



Insights basés sur le type d'enzyme



Le marché de la technologie des enzymes médicales, par type d'enzyme, est segmenté en enzymes digestives, enzymes thrombolytiques, hydrolases et endonucléases. Le segment des hydrolases détenait la plus grande part de marché en 2020 ; en outre, le segment des enzymes thrombolytiques devrait enregistrer le TCAC le plus élevé de 7,2 % du marché au cours de la période de prévision.




Marché de la technologie des enzymes médicales, par type d'enzyme - 2020 et 2028




Informations basées sur les applications



Le marché de la technologie des enzymes médicales, par application, est segmenté en traitement des maladies, outils de diagnostic, recherche biomédicale, etc. . Le segment du traitement des maladies détenait la plus grande part du marché en 2020, et le même segment devrait enregistrer le TCAC le plus élevé de 7,1 % sur le marché au cours de la période de prévision.



Perspectives stratégiques



< p>Les entreprises opérant sur le marché de la technologie des enzymes médicales adoptent des stratégies organiques telles que les lancements et les extensions de produits pour étendre leur empreinte et leur portefeuille de produits dans le monde entier, ainsi que pour répondre aux demandes croissantes.



Par type d'enzyme


  • Enzyme Digestive


  • L-asparaginase

  • Lactase

  • Autres


  • Enzyme thrombolytique


  • Streptokinase

  • Urokinase

  • Autres


  • Hydrolases Enzyme


  • Hyaluronidase

  • Lysozymes

  • Autres


  • Endonucléases Enzyme


  • Benzonase

  • Autres



Par application




  • Traitements des maladies

  • Outils de diagnostic

  • Recherche biomédicale

  • Autres



Par géographie




  • Nord Amérique

    • États-Unis

    • Canada

    • Mexique


  • Europe

    • France
    • Allemagne

    • Italie

    • Royaume-Uni

    • Espagne

    • Reste de l'Europe

  • Asie-Pacifique (APAC)

    • Chine

    • Inde

    • Corée du Sud

    • Japon

    • Australie

    • Reste de l'APAC


  • Moyen-Orient et Afrique (MEA)

    • Afrique du Sud

    • Arabie saoudite
    • EAU

    • Reste de la MEA


  • Amérique du Sud et centrale (SCAM)

    • Brésil
    • < li>Argentine
    • Reste de SCAM




Profils d'entreprise




  • Merck
  • < li>Thermo Fisher Scientific Inc.
  • Novozymes

  • TAKEDA PHARMACEUTICAL COMPANY LIMITED

  • Agilent Technologies, Inc.

  • Danaher (Cytiva)

  • Sanofi

  • Asahi Kasei Corporation

  • Promega Corporation

  • Amano Enzyme Inc

  • Genzyme Corporation
  • < /ul>
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Medical Enzyme Technology?

Enzymes are proteins produced in living cells of plants, animals, and microorganisms. All living organisms require enzymes for growth and for the production and utilization of energy which is essential for life. In the living cell, enzymes act as catalysts to speed up the chemical reactions which control life processes. Enzymes have been significant industrial products for more than a hundred years. However, the range of potential applications is increasing rapidly.

What are the driving factors for the Medical Enzyme Technology market across the globe?

Key factors that are driving the market are advent of recombinant DNA technology, it has become possible to make formerly rare enzymes in large quantities and hence to reduce cost. Also, in pharmaceutical manufacturing, the desire to make chirally pure compounds is leading to new opportunities. Technological advances have facilitated the use of enzymes over an increasingly broad range of process conditions.

What is the cost of Medical Enzyme Technology?

The costs of the Medical Enzyme Technology are much higher, and they may cost US$ 5–50, or more, per enzyme type. The cost may also differ from product to product types.

The List of Companies - Medical Enzyme Technology Market

  1. Merck
  2. Thermo Fisher Scientific Inc.
  3. Novozymes
  4. TAKEDA PHARMACEUTICAL COMPANY LIMITED
  5. Agilent Technologies, Inc.
  6. Danaher (Cytiva)
  7. Sanofi
  8. Asahi Kasei Corporation
  9. Promega Corporation
  10. Amano Enzyme Inc
  11. Genzyme Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports